chevron_leftBack
As of 23 June 2026, Norris Medicines Ltd. has a market cap of $1.53M USD, ranking #47812 globally and #4776 in India.
It ranks #4244 in the Healthcare sector, and #1342 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.53MUSD
145.11M INR
Enterprise Value
$3.8MUSD
359.18M INR
Revenue (TTM)
$998.65KUSD
94.44M INR
EBITDA (TTM)
$50.17KUSD
4.74M INR
Net Income (TTM)
-$59.18KUSD
-5.6M INR
EBITDA Margin
5%
Profit Margin
-5.9%
PS Ratio
1.5
PB Ratio
-0.9
EV/EBITDA
75.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Vimal Shah
open_in_new
Employees
33
Founded
1990
Website
norrispharma.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.6% | 3.5% | 16% | 13% | -5% | -12% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
524414
(NORRIS)
Norris Medicines Ltd
ISIN: INE744C01029
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
14.51 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Norris Medicines Ltd.
Norris Medicines Limited manufactures and sells pharmaceutical formulations in India. The company offers nonsterile dosage products, such as tablets, capsules, liquid orals, and copical ointments, as well as injections and medicinal formulations. Its products include antibiotics, anti-inflammatory/pain management, antiemetic, nutrition, gastro, cough/cold, skin and allergy, antimalarial, diabetic, cardiac, dental, and other medicine products. The company also provides contract and loan license manufacturing services for pharma companies. It exports its products. Norris Medicines Limited was incorporated in 1990 and is based in Ankleshwar, India.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: SUNPHARMA
|
$45.13B
3M%
4.27T INR
|
39.1
|
|
NSE: DIVISLAB
|
$18.34B
1M%
1.73T INR
|
70.0
|
|
NSE: TORNTPHARM
|
$15.14B
987K%
1.43T INR
|
63.0
|
|
NSE: DRREDDY
|
$11.71B
763K%
1.11T INR
|
19.6
|
|
NSE: MANKIND
|
$9.85B
642K%
931.67B INR
|
52.2
|
|
NSE: ZYDUSLIFE
|
$9.69B
632K%
916.53B INR
|
18.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
50M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
36M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
24M%
|
97.4
|
|
SIX: RO
|
$316.71B
21M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$285.49B
19M%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
18M%
|
15.1
|
chevron_leftBack